SCHEDULE 13G FOR AQUINOX PHARMACEUTICALS FOR JOHNSON & JOHNSON

Company

JOHNSON & JOHNSON

Filed

February 6, 2015

Accession Number

0000904454-15-000065

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →